At the healthcare conference, Moderna lowered expected 2025 revenue to the range of $1.5 billion to $2.5 billion -- down from ...
No scientific studies have established a causal relationship between the Pfizer vaccine and conditions that cause the ...
1d
In a report released today, Terence Flynn from Morgan Stanley assigned a Hold rating on Moderna (MRNA – Research Report), with a price target ...
The messenger RNA (mRNA) pioneer provided a business and pipeline update at the J.P. Morgan Healthcare Conference on Monday.
Cases of norovirus infections are surging, but coming up with a way to prevent them has proven to be a challenge.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback